Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIPLOSTIM vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROMIPLOSTIM vs ROSIGLITAZONE: Safety Overview

Metric ROMIPLOSTIM ROSIGLITAZONE
Total FAERS Reports 7,510 45,976
Deaths Reported 865 4,661
Death Rate 11.5% 10.1%
Hospitalizations 1,812 23,675
Average Patient Age 56.7 yrs 60.2 yrs
% Female Patients 55.7% 42.8%
FDA Approval Date N/A Jan 25, 2013
Manufacturer Amgen, Inc N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription Discontinued